Definium Therapeutics issues inducement stock options for 56,650 shares to new hires
DFTX•Vesting terms and plan details
The awards vest over four years, with 25% vesting after the first year and the remaining 75% vesting monthly over the following three years.
The options were issued under the company’s 2026 Inducement Plan.
Inducement stock options granted to new hires
Definium Therapeutics issued inducement stock options covering 56,650 common shares to three newly hired non-executive employees.
The grants carry an effective date of Sept. 14, 2026. The exercise price was set at the closing price of the common shares on the grant date.
